With an aim to help state governments tide over the financial problems triggered by the COVID-19 pandemic, the RBI on September 29 extended by six months the additional flexibility provided to states to raise funds through market borrowing and overdraft.
The Reserve Bank in April provided additional flexibility to states and Union Territories (UTs) to raise funds to deal with the COVID-19 crisis. The flexibility was available till September 30, 2020.
On a review, it has been decided to extend the measures announced on April 17, 2020 and April 7, 2020 with regard to increase in WMA Limits of states/UTs and overdraft (OD) regulations, respectively, for a further period of 6 months till March 31, 2021, the central bank said in a press release.
With a view to provide greater comfort to state governments in undertaking COVID-19 containment and mitigation measures, and to enable them to plan their market borrowings, RBI in April had increased Ways and Means Advances (WMA) limit of states and UTs by 60 percent over and above the level as on March 31, 2020.
WMA is temporary advances given by RBI to government to tide over any mismatch in receipts and payments. Similarly, to help state governments tide over their cash flow mismatches, RBI had relaxed the OD regulations with effect from April 7, 2020.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The central bank decided to increase the number of days for which a state/ UT can be in overdraft continuously to 21 working days from 14. Also, the number of days for which a state/ UT can be in overdraft in a quarter was increased to 50 working days from 36.For all commodities related news, click here